Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20508,836,1.00 [0.87-1.15],0.9627490657980672
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20467,164,0.91 [0.66-1.27],0.5813327033339353
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22132,161,0.82 [0.58-1.18],0.2868594436337708
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15599,629,1.03 [0.88-1.21],0.7000691287507999
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22076,105,0.88 [0.58-1.35],0.5725446719811804
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21213,76,0.96 [0.60-1.52],0.8546725242142512
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23255,104,0.87 [0.57-1.34],0.5393579521135325
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23249,69,0.86 [0.51-1.47],0.5905262847493802
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20672,49,0.87 [0.47-1.61],0.6577775489010178
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22719,104,0.98 [0.66-1.45],0.9256797470737186
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22680,65,0.94 [0.56-1.57],0.8121187099783548
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23318,67,0.59 [0.30-1.13],0.1085700345923934
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23294,85,0.91 [0.57-1.43],0.6682204296404317
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23291,82,0.92 [0.58-1.45],0.7101965736331752
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,22999,58,1.45 [1.06-1.98],0.0204414085581552
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22326,359,0.94 [0.76-1.17],0.5823005468193174
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22080,113,0.69 [0.43-1.10],0.1215493132179964
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22215,248,0.95 [0.73-1.23],0.6953908850671573
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19083,44,0.80 [0.40-1.61],0.5290263664453589
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19093,54,0.63 [0.31-1.27],0.1952745066972566
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19260,221,1.06 [0.82-1.36],0.6594732388589994
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19267,228,1.05 [0.82-1.35],0.6751778176460344
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19609,570,0.92 [0.77-1.10],0.3461472479284387
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19086,47,0.89 [0.48-1.65],0.7102091499680447
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20936,868,1.00 [0.88-1.15],0.9704321853656616
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22429,253,0.86 [0.65-1.14],0.3028162823115523
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23030,100,0.67 [0.40-1.12],0.1257856595988905
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23401,80,0.68 [0.38-1.20],0.1783869451498304
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,23220,54,0.96 [0.55-1.68],0.8994919151561609
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23399,58,0.59 [0.29-1.20],0.1453672317447663
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Stomach,23444,44,0.56 [0.24-1.28],0.1670099126552992
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,23257,243,0.88 [0.66-1.16],0.3519302550891227
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23399,99,0.64 [0.38-1.07],0.0887791977055774
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23400,92,0.93 [0.60-1.43],0.7296578192628833
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23334,61,0.87 [0.50-1.52],0.618251552645539
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma, any site",23336,60,0.84 [0.48-1.50],0.5628835721083771
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi,23253,227,1.00 [0.77-1.29],0.9702278570391444
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23402,107,0.85 [0.56-1.30],0.4597534206605187
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Other benign neoplasms of skin,23308,193,0.93 [0.69-1.25],0.6232746471581838
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of breast,23388,120,0.83 [0.56-1.25],0.3853721910046987
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Leiomyoma of uterus,22970,852,0.94 [0.82-1.08],0.3879386892260518
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22289,230,0.93 [0.71-1.22],0.614836656232755
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22052,377,1.10 [0.91-1.32],0.3185487614540563
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22052,377,1.10 [0.91-1.32],0.3185487614540563
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),20756,333,1.23 [1.04-1.47],0.0179749905376769
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22938,84,1.26 [0.91-1.76],0.1678486860580639
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23151,82,0.85 [0.52-1.38],0.5055360263060562
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19446,750,0.94 [0.80-1.10],0.4216938781006082
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21500,747,0.93 [0.79-1.08],0.3407597106455277
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,21875,92,0.82 [0.51-1.32],0.4203316108053661
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22564,46,1.38 [0.93-2.02],0.1059298805085721
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21865,82,0.86 [0.53-1.40],0.5394740143618444
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22127,344,1.01 [0.81-1.26],0.923010810047132
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22117,334,1.01 [0.81-1.26],0.9185443892076168
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21694,158,1.12 [0.83-1.52],0.4563787165589034
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21696,155,1.13 [0.83-1.53],0.434454606443566
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19280,584,0.91 [0.76-1.09],0.3134198256771615
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",18764,68,0.65 [0.35-1.21],0.1718936545415917
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19240,544,0.91 [0.75-1.10],0.3203058230807691
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18741,45,0.68 [0.32-1.42],0.3038387812298792
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18752,56,1.08 [0.67-1.74],0.7468364901325153
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Any mental disorder,19793,506,0.79 [0.64-0.97],0.025643295274268
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19384,97,0.76 [0.47-1.22],0.2507271869370943
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23233,63,0.73 [0.40-1.33],0.3099133230603296
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23265,37,0.82 [0.40-1.69],0.5938337199839714
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22218,32,0.78 [0.35-1.74],0.5497082879341492
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23402,32,0.78 [0.35-1.76],0.5576790822826911
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19319,32,0.80 [0.36-1.76],0.5712831366680864
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Alcohol dependence,22208,22,1.16 [0.60-2.25],0.6557712605769803
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Smoking dependency,22125,30,0.62 [0.24-1.59],0.3209320353726409
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19325,38,0.82 [0.39-1.70],0.591127169882281
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19595,308,0.86 [0.67-1.10],0.2319170134789153
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Depression,21747,275,0.88 [0.68-1.14],0.3204946752208998
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Depression or dysthymia,19417,238,0.90 [0.69-1.19],0.4724564989421842
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19413,126,0.64 [0.41-1.02],0.0596277426179826
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Other anxiety disorders,21820,64,0.40 [0.19-0.84],0.0160171507962499
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Neurological diseases,20314,1386,0.89 [0.79-1.00],0.0580580792214834
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18584,161,0.96 [0.70-1.31],0.7811661804304555
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23274,131,0.94 [0.66-1.35],0.74933332188331
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22338,362,0.98 [0.80-1.21],0.8715411374747127
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Epilepsy,22090,114,1.13 [0.83-1.56],0.4354998881020994
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Migraine,22082,106,1.15 [0.83-1.59],0.4008507369191405
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23064,98,1.18 [0.85-1.64],0.3271486273806514
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22861,51,0.67 [0.33-1.38],0.2767286825870557
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,22063,87,0.84 [0.52-1.36],0.4737703411867214
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,23095,61,0.84 [0.47-1.50],0.5595715579859795
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22273,714,0.88 [0.75-1.04],0.1293336939317914
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21661,102,0.82 [0.53-1.29],0.3972584365964428
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22012,453,0.96 [0.80-1.16],0.6983370652390009
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23228,64,0.88 [0.51-1.50],0.6354709173382579
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hemiplegia,23213,49,0.66 [0.32-1.35],0.2542804934960253
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,23028,104,1.09 [0.77-1.54],0.6271499913077072
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22815,364,0.87 [0.70-1.10],0.2484321271861913
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22660,209,0.85 [0.63-1.16],0.3111318866747924
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22513,62,0.83 [0.47-1.47],0.5283471728803337
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22563,112,0.69 [0.43-1.11],0.1251772646620601
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22542,91,0.94 [0.61-1.45],0.785836791081663
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19901,145,1.21 [0.91-1.61],0.1869014384007544
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20111,355,0.99 [0.79-1.23],0.8960831411932321
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22561,150,1.17 [0.89-1.54],0.2503716199612853
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23218,28,0.62 [0.23-1.66],0.3372875730127875
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1500,28,0.70 [0.26-1.87],0.4735031547871849
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",21746,28,0.62 [0.23-1.67],0.3438500776019622
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22848,76,1.10 [0.72-1.67],0.6557419292292407
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22811,39,0.86 [0.42-1.76],0.6830586955612846
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22718,77,1.26 [0.89-1.78],0.1882795195331135
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22939,89,0.68 [0.40-1.16],0.1561216743386639
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23335,106,1.18 [0.86-1.62],0.3082392510488482
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22777,93,0.76 [0.47-1.25],0.2780618804602837
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17244,2351,0.86 [0.77-0.95],0.0031280562878343
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22962,66,0.96 [0.58-1.58],0.8608501598926696
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18142,1728,0.84 [0.75-0.95],0.0048739974975887
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertension,18157,1743,0.84 [0.74-0.94],0.0030528767547425
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16446,32,0.57 [0.22-1.49],0.2539587532046701
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22031,602,1.00 [0.85-1.18],0.9820411361785516
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,21848,419,1.09 [0.91-1.30],0.3742056919312037
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22876,122,1.11 [0.81-1.53],0.5217784933809626
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22940,186,1.03 [0.78-1.36],0.840507865942796
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23381,24,0.81 [0.31-2.11],0.6611244343106655
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21506,77,0.93 [0.58-1.50],0.7680798234643655
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21808,388,0.93 [0.75-1.16],0.5116428658649465
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22764,85,0.76 [0.45-1.28],0.301884630566973
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22858,184,0.80 [0.57-1.13],0.2133858411477058
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22767,88,1.33 [0.98-1.80],0.0633733201538922
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22767,88,1.33 [0.98-1.80],0.0633733201538922
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16499,85,1.33 [0.98-1.81],0.0674732895302798
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20406,31,0.64 [0.25-1.62],0.3491380700279366
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,20438,63,1.01 [0.62-1.63],0.9742340709428954
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14086,83,0.56 [0.31-1.02],0.0564722851968615
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14238,235,0.97 [0.75-1.27],0.847764687979081
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20418,43,0.66 [0.31-1.44],0.3000224834336656
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,20422,47,1.03 [0.59-1.77],0.926496536303462
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22751,82,0.71 [0.41-1.23],0.2182407055200551
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22786,109,0.60 [0.36-1.00],0.0483519644778594
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22821,82,0.62 [0.35-1.11],0.1087770216810874
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22880,70,0.67 [0.37-1.24],0.2020308582688034
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22586,58,0.82 [0.45-1.50],0.5180867576390905
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22623,95,1.24 [0.90-1.69],0.1854289932061866
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22072,110,0.87 [0.57-1.32],0.5027768799464507
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22049,87,0.95 [0.62-1.47],0.8215919558802883
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23251,86,0.94 [0.60-1.47],0.795678072474806
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Varicose veins,22488,526,1.02 [0.86-1.20],0.8539303319041158
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypotension,22506,71,1.25 [0.88-1.79],0.2179138439401129
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19071,1799,0.98 [0.89-1.08],0.6885035152431004
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23251,114,1.00 [0.69-1.44],0.993414727679522
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22082,173,1.04 [0.78-1.38],0.7846224996843437
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22065,156,1.11 [0.84-1.47],0.4542696015726634
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22664,202,0.81 [0.58-1.12],0.1963416930721471
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22659,197,0.84 [0.61-1.16],0.2819510032063329
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22784,481,1.02 [0.86-1.22],0.8145044277710707
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22406,103,1.05 [0.73-1.51],0.7968956296127703
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Nasal polyp,22373,70,0.99 [0.62-1.58],0.9617351512612824
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22606,303,1.04 [0.84-1.29],0.7372106429087737
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22422,119,1.17 [0.86-1.58],0.3199074780806524
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11274,55,1.15 [0.71-1.85],0.5729847183919468
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20898,987,0.97 [0.85-1.10],0.6444037248279819
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Early onset COPD,22554,134,1.13 [0.84-1.53],0.404467444649199
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22571,151,1.09 [0.81-1.46],0.5761218226965162
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22571,151,1.09 [0.81-1.46],0.5761218226965162
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21665,847,0.96 [0.83-1.10],0.5531813821003735
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Asthma,17421,847,0.95 [0.82-1.10],0.503642790594143
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17265,847,0.95 [0.82-1.10],0.5089073502921242
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17409,835,0.96 [0.83-1.11],0.6141854686534935
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23164,76,1.30 [0.94-1.81],0.1161648602022988
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21878,58,1.41 [0.99-2.00],0.0580900349087684
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23226,58,1.39 [0.99-1.95],0.0602624570899337
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21871,51,1.30 [0.86-1.96],0.2127362652288206
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural effusion,21885,70,0.79 [0.45-1.37],0.3961376045107276
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,21978,163,0.89 [0.63-1.24],0.4887346724266748
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22452,78,0.77 [0.45-1.31],0.3314782189185237
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16251,5092,1.00 [0.94-1.07],0.9246970548914908
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22945,397,0.98 [0.81-1.20],0.8626790235646227
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23400,88,1.02 [0.68-1.53],0.9300816867377812
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impacted teeth,23405,80,1.00 [0.65-1.54],0.9937567670296324
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Dental caries,22639,91,1.03 [0.69-1.52],0.8935565764976494
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22647,99,0.99 [0.67-1.47],0.963499685521504
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23391,96,1.06 [0.73-1.55],0.7584254899799785
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22642,94,0.89 [0.58-1.39],0.6172721985208296
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22392,61,0.69 [0.36-1.31],0.252751273226696
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23318,39,0.59 [0.25-1.39],0.2271435816489354
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17727,185,0.91 [0.66-1.25],0.5599005734492067
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19509,1967,1.00 [0.91-1.10],0.9576055034904248
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophagitis,17789,247,1.08 [0.86-1.36],0.5177198658979769
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18174,632,0.89 [0.75-1.06],0.1992507908992685
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17606,64,1.31 [0.92-1.86],0.1376547833415524
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17660,118,1.26 [0.95-1.67],0.1046508430812342
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17574,32,0.46 [0.17-1.27],0.1332166637944754
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,17664,122,0.87 [0.58-1.29],0.4835062019920619
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17605,63,0.98 [0.59-1.64],0.9469900226940176
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23361,49,1.07 [0.63-1.81],0.8013767891460433
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,17652,110,1.05 [0.74-1.50],0.7759723898286971
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18264,722,0.99 [0.85-1.15],0.89734288595546
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,23299,130,0.99 [0.70-1.39],0.9470519386668392
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18039,497,1.12 [0.96-1.31],0.150502970619345
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17685,143,0.87 [0.60-1.26],0.452077506364108
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23323,124,1.06 [0.76-1.47],0.7287353884334846
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,23276,107,0.95 [0.64-1.41],0.8090279538281089
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Hernia,20991,1025,1.05 [0.93-1.19],0.4048847074488831
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,20024,58,1.46 [1.07-2.01],0.0184207485935113
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,20030,64,0.93 [0.55-1.59],0.7953888826894959
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ventral hernia,20052,86,0.98 [0.64-1.52],0.9396963844008048
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20788,822,1.02 [0.88-1.17],0.8204199835486197
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22517,774,1.01 [0.88-1.16],0.8985635922675591
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18594,1851,1.00 [0.91-1.10],0.9550212419757736
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23159,54,1.07 [0.65-1.77],0.783587313877811
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23388,78,1.06 [0.70-1.61],0.7917634238646978
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn disease,21821,78,1.05 [0.69-1.60],0.8027599775646639
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21800,57,0.73 [0.39-1.39],0.343113980892999
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23320,112,1.17 [0.85-1.60],0.3305445783005568
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21855,112,1.16 [0.85-1.59],0.34013693550799
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21841,98,1.15 [0.82-1.62],0.4030037917603823
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22401,658,0.95 [0.81-1.12],0.541635373640823
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22391,648,0.95 [0.81-1.12],0.5653063492787058
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16829,86,0.92 [0.58-1.44],0.707419238220989
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal stricture,23033,86,0.92 [0.58-1.45],0.7097919783480573
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16797,54,0.94 [0.54-1.64],0.8210093316203997
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17311,568,1.02 [0.86-1.21],0.8016641805084762
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16944,201,0.95 [0.72-1.27],0.7469847417603144
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17069,326,1.13 [0.94-1.36],0.1920412263884826
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Constipation,22004,291,1.17 [0.96-1.42],0.1248400989647038
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23007,107,0.76 [0.48-1.21],0.2477946449902281
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16853,110,0.98 [0.68-1.42],0.9194147238616698
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16781,38,0.53 [0.22-1.30],0.1668658285971871
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17500,757,0.97 [0.83-1.12],0.6533895361974698
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,16943,200,0.91 [0.67-1.23],0.53010808246724
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22994,94,0.78 [0.48-1.26],0.3146106123658644
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of liver,22769,85,1.04 [0.69-1.56],0.8674200938257113
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,22729,45,0.94 [0.51-1.74],0.8431834767287887
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22096,734,0.97 [0.84-1.13],0.7323775737875993
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,21973,611,0.91 [0.76-1.08],0.2733029768967729
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholecystitis,21474,112,1.13 [0.81-1.56],0.4737231193177011
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21417,55,0.99 [0.58-1.67],0.9552992037084712
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21412,50,1.20 [0.76-1.88],0.4351311146392843
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23301,50,1.20 [0.76-1.90],0.4227693437265283
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22270,254,0.96 [0.74-1.24],0.7603285765994325
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22103,87,1.16 [0.81-1.66],0.4316174893861342
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Coeliac disease,22091,75,1.20 [0.90-1.61],0.2215597576149788
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22049,33,1.01 [0.52-1.97],0.9742299069212168
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22155,139,0.87 [0.60-1.26],0.4528343962693286
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,GI-bleeding,22147,131,0.87 [0.59-1.28],0.4784707770179199
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20756,1379,0.99 [0.89-1.11],0.9004226555518232
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23040,100,1.05 [0.73-1.52],0.7821852883266154
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23054,389,0.90 [0.73-1.12],0.3501599039161219
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22106,587,1.03 [0.88-1.21],0.6767236760416299
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22730,278,0.98 [0.77-1.24],0.8512630975921789
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22516,64,0.55 [0.28-1.08],0.0799617617446599
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22629,177,1.12 [0.86-1.46],0.3994411170976445
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23180,77,1.23 [0.86-1.75],0.2549216999223105
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23158,55,1.29 [0.88-1.90],0.1932634066295714
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23145,42,1.14 [0.68-1.92],0.6111921371276179
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23217,50,0.86 [0.46-1.62],0.6489650945721572
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23214,47,0.68 [0.33-1.43],0.3125900139142782
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22715,50,0.99 [0.57-1.73],0.9817611321720864
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22969,304,0.90 [0.71-1.15],0.4053333123174995
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21603,84,0.84 [0.52-1.38],0.4962213908582343
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21648,129,1.08 [0.79-1.49],0.6212172664211294
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21613,94,0.95 [0.62-1.44],0.8005902931414279
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21736,217,1.03 [0.79-1.33],0.8394797503598144
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21715,196,1.01 [0.76-1.33],0.9637720683239612
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16511,3754,0.95 [0.88-1.03],0.21969861239382
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17990,2155,0.92 [0.84-1.02],0.098055239987818
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21036,1134,0.97 [0.86-1.10],0.635215986549357
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16026,191,1.11 [0.86-1.43],0.4150540250427157
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16278,443,0.88 [0.71-1.08],0.2223508992779643
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22954,183,1.14 [0.88-1.46],0.3161389593730869
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22968,168,1.15 [0.88-1.49],0.3054931614806349
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16872,1037,0.90 [0.78-1.03],0.1349840029748031
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19168,1037,0.91 [0.79-1.05],0.1880861954652664
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15846,11,0.54 [0.10-2.95],0.4795457924764236
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23277,11,0.56 [0.11-2.93],0.4932837474994275
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16061,226,0.73 [0.53-1.01],0.0608844495437436
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,15910,75,0.69 [0.38-1.23],0.2073623108259533
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16101,266,1.01 [0.80-1.29],0.9040855843167848
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23259,138,1.10 [0.81-1.50],0.5423984263164386
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16236,401,0.90 [0.72-1.12],0.3306523254221809
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16237,402,0.79 [0.62-1.00],0.0520880769227627
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17036,1201,0.87 [0.76-0.99],0.0343118513609181
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),15934,99,0.95 [0.63-1.43],0.8042803390158259
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16190,355,0.94 [0.75-1.17],0.5580249789829665
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15903,68,0.93 [0.57-1.54],0.7918978733689463
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),15923,88,0.64 [0.37-1.11],0.1135051453102515
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16148,313,0.94 [0.74-1.18],0.5872912836381898
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16101,266,0.91 [0.70-1.18],0.467238440131122
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17428,253,0.73 [0.54-1.00],0.0466048605843569
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22717,207,1.12 [0.88-1.43],0.3518476335693744
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22592,82,1.20 [0.84-1.72],0.3098322758744222
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20068,73,0.80 [0.46-1.37],0.4151390460672295
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20265,270,0.97 [0.76-1.24],0.8026956373241255
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20877,882,0.92 [0.80-1.06],0.2730277288383251
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20182,187,1.09 [0.84-1.42],0.5175967984036279
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20064,69,0.46 [0.23-0.92],0.0272741955014609
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20699,704,0.92 [0.79-1.08],0.3229215356913559
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20037,42,1.16 [0.69-1.94],0.5767514599917536
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20203,208,0.89 [0.66-1.20],0.4429856636928039
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20084,89,1.06 [0.72-1.56],0.770863392670591
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20069,74,0.72 [0.41-1.27],0.2561711723200803
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20124,129,1.17 [0.88-1.56],0.2807676135225844
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20063,68,0.95 [0.58-1.54],0.8220896770598793
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20304,309,0.82 [0.63-1.06],0.1247826362915734
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20232,330,1.01 [0.82-1.25],0.8909903953227928
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19963,61,1.05 [0.66-1.68],0.8382689725088102
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19995,93,0.62 [0.36-1.07],0.0844745886772954
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20023,121,1.23 [0.93-1.62],0.1485129287108333
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19939,37,0.36 [0.14-0.97],0.0443357248012142
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19948,46,0.67 [0.32-1.41],0.2919562681921357
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19937,35,0.75 [0.33-1.71],0.4974901842656362
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20133,231,0.95 [0.72-1.24],0.6834813674503368
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19953,51,0.96 [0.55-1.67],0.878862052695704
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19958,56,0.81 [0.44-1.49],0.4984597068109542
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20015,113,1.07 [0.76-1.50],0.6897594394446955
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19973,71,0.92 [0.56-1.50],0.7297075079281217
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20368,466,0.98 [0.81-1.17],0.79517494509476
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20067,165,0.96 [0.70-1.31],0.7959515325141795
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20158,256,0.92 [0.71-1.19],0.5368941079684255
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21119,208,0.95 [0.71-1.25],0.6948818038937916
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21317,406,0.98 [0.81-1.19],0.8618062902796748
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20944,33,0.47 [0.17-1.26],0.132459828891653
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20960,49,1.54 [1.13-2.10],0.006819492861422
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21001,90,1.34 [1.01-1.79],0.0419228398966677
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19227,5256,1.00 [0.94-1.06],0.9003022347528881
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,21459,149,0.77 [0.53-1.13],0.1784291264737685
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21345,35,0.80 [0.37-1.73],0.5643615858995175
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21626,25,0.73 [0.29-1.89],0.5211178833157916
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21630,29,0.81 [0.36-1.86],0.6244509068455123
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21631,30,1.02 [0.51-2.03],0.96166804850994
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23228,104,0.63 [0.38-1.05],0.0735573182364154
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23142,50,1.02 [0.60-1.74],0.9461157167850456
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23202,78,0.59 [0.32-1.07],0.0827393274307309
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23155,31,0.86 [0.39-1.88],0.708286583452255
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21577,1076,1.01 [0.89-1.13],0.9307321463924676
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,20607,106,0.86 [0.56-1.31],0.4835364279535532
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20574,73,1.04 [0.67-1.61],0.8691592925081271
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20641,140,1.09 [0.80-1.47],0.5936074557978872
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20580,79,0.95 [0.60-1.49],0.8262274870516377
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21353,852,0.99 [0.87-1.14],0.923178184656573
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23177,417,1.02 [0.85-1.23],0.8261863453062047
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22888,128,0.77 [0.51-1.17],0.2263825283582945
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,22902,142,1.26 [0.97-1.62],0.0782112496959767
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22864,104,0.94 [0.63-1.40],0.7616471297427492
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23118,479,0.93 [0.77-1.12],0.4520492565350356
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,22754,115,0.70 [0.44-1.11],0.1248290929785097
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22853,214,1.03 [0.80-1.33],0.8247390349992273
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21385,3943,1.02 [0.95-1.09],0.6274576205337109
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17743,301,0.92 [0.72-1.17],0.4917725513951663
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17527,85,1.07 [0.72-1.59],0.7383232137358668
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17578,136,0.67 [0.44-1.04],0.075576760464712
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18127,685,1.01 [0.87-1.17],0.9232787597997612
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17785,343,0.99 [0.80-1.22],0.9121732404933932
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18259,817,1.07 [0.94-1.22],0.3056154887107293
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17714,272,1.22 [1.01-1.48],0.0384441696012664
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17820,378,1.11 [0.92-1.34],0.266243423355696
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17527,85,1.04 [0.70-1.57],0.8321622568426499
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17606,164,1.24 [0.97-1.57],0.0868711550359278
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23403,228,1.18 [0.95-1.47],0.134832029973699
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23412,216,1.16 [0.93-1.46],0.1927069320312138
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23432,117,1.18 [0.87-1.60],0.2784342053757956
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23424,129,1.21 [0.91-1.60],0.1820556142103424
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17567,125,1.13 [0.82-1.54],0.4551710059846039
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17545,103,1.12 [0.79-1.58],0.5298080806752219
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17563,121,1.02 [0.72-1.45],0.907244040946257
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23345,396,0.77 [0.61-0.98],0.0310203914310137
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18597,1155,0.92 [0.81-1.04],0.1854859365313818
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18197,755,0.93 [0.80-1.08],0.358092624183241
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23421,172,0.88 [0.63-1.22],0.431293151888475
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17838,396,0.95 [0.77-1.17],0.627566727962015
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17710,268,0.95 [0.74-1.21],0.6675388825841906
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18223,781,1.08 [0.94-1.23],0.293170008234785
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female infertility,17529,87,0.94 [0.60-1.47],0.7767103315062418
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17522,80,1.00 [0.64-1.56],0.990558456976899
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23429,723,0.82 [0.69-0.98],0.0273084669971787
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23435,988,0.94 [0.81-1.08],0.3853768145436598
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23430,384,1.13 [0.93-1.36],0.2123565345896085
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23155,109,0.82 [0.53-1.27],0.3787567756018026
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23202,156,1.27 [0.99-1.63],0.0616140217594814
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23180,134,1.11 [0.82-1.52],0.493689976068366
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23445,140,0.84 [0.58-1.23],0.3777886715600078
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23447,139,0.85 [0.59-1.24],0.4104043468695886
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23444,355,0.87 [0.68-1.10],0.2306602594737858
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23193,104,0.97 [0.65-1.44],0.8707117038977558
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23289,200,0.92 [0.68-1.24],0.5664152981310184
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,22829,123,0.96 [0.67-1.38],0.8321832515686939
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,22874,168,0.98 [0.73-1.33],0.915885866999801
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,22908,202,0.93 [0.70-1.25],0.643421822431236
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,22831,125,0.95 [0.66-1.36],0.7715756445779405
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,22821,115,0.94 [0.65-1.37],0.7476078697380532
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,22825,119,0.63 [0.39-1.01],0.054058687356864
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22638,191,0.78 [0.55-1.11],0.1717877039909089
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],22809,362,0.79 [0.61-1.02],0.0656402816385506
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,22997,550,0.95 [0.79-1.15],0.6060326733026631
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23449,143,1.06 [0.78-1.46],0.7048372474878346
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22248,110,1.06 [0.74-1.50],0.7625913755666078
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22528,81,0.88 [0.55-1.43],0.6180603185716684
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23455,277,1.11 [0.90-1.39],0.3324022709473949
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23393,215,1.14 [0.89-1.46],0.2877217952055948
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23444,208,1.07 [0.83-1.39],0.6039191090315774
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23434,198,1.10 [0.85-1.43],0.4729396158424942
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23197,42,0.97 [0.52-1.80],0.92054123860032
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21008,534,1.06 [0.90-1.25],0.4701107516871474
